Paper39237657
Impact of time intervals on drug efficacy and phenotypic outcomes in acute respiratory distress syndrome in mice.
Paris-Robidas S and 6 others. Sci Rep, 2024. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Impact of time intervals on drug efficacy and phenotypic outcomes in acute respiratory distress syndrome in mice. Papers, record 39237657. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39237657
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Impact of time intervals on drug efficacy and phenotypic outcomes in acute respiratory distress syndrome in mice.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Respiratory Distress Syndrome | Major topic |
| Lipopolysaccharides | Major topic |
| Disease Models, Animal | Major topic |
| Mice, Inbred C57BL | Major topic |
| Phenotype | Major topic |
| Animals | |
| Mice | |
| Male | |
| Lung | |
| Bronchoalveolar Lavage Fluid | |
| Time Factors | |
| Cytokines | |
| Neutrophils |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 291453 | Fonds de Recherche du Québec- Nature et Technologies | PubMed | ||
| 13380 | Ministère de l'Éducation et de l'Enseignement supérieur | PubMed |
Source PubMed
References50
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16809643 | TLR4 gene dosage contributes to endotoxin-induced acute respiratory inflammation. | J Leukoc Biol | 2006 | https://conductscience.org/library/papers/16809643 | PubMed |
| 2 | 35168919 | Impact of corticosteroid therapy on the survival of critical COVID-19 patients admitted into an intensive care unit. | Rev Esp Anestesiol Reanim (Engl Ed) | 2022 | https://conductscience.org/library/papers/35168919 | PubMed |
| 3 | 26115403 | New Metrics for Evaluating Viral Respiratory Pathogenesis. | PLoS One | 2015 | https://conductscience.org/library/papers/26115403 | PubMed |
| 4 | 27496101 | Evidence for chemokine synergy during neutrophil migration in ARDS. | Thorax | 2017 | https://conductscience.org/library/papers/27496101 | PubMed |
| 5 | 32043986 | Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial. | Lancet Respir Med | 2020 | https://conductscience.org/library/papers/32043986 | PubMed |
| 6 | 32474442 | Strain-Dependent Variability of Early Discovery Small Molecule Pharmacokinetics in Mice: Does Strain Matter? | Drug Metab Dispos | 2020 | https://conductscience.org/library/papers/32474442 | PubMed |
| 7 | 27104958 | Dexamethasone Attenuates LPS-induced Acute Lung Injury through Inhibition of NF-κB, COX-2, and Pro-inflammatory Mediators. | Immunol Invest | 2016 | https://conductscience.org/library/papers/27104958 | PubMed |
| 8 | 35415281 | Dexamethasone-loaded ROS-responsive poly(thioketal) nanoparticles suppress inflammation and oxidative stress of acute lung injury. | Bioact Mater | 2022 | https://conductscience.org/library/papers/35415281 | PubMed |
| 9 | 29336940 | Myeloperoxidase: Its role for host defense, inflammation, and neutrophil function. | Arch Biochem Biophys | 2018 | https://conductscience.org/library/papers/29336940 | PubMed |
| 10 | 22212433 | A mechanism-based pharmacokinetic/pharmacodynamic model for CYP3A1/2 induction by dexamethasone in rats. | Acta Pharmacol Sin | 2012 | https://conductscience.org/library/papers/22212433 | PubMed |
| 11 | 18621912 | Animal models of acute lung injury. | Am J Physiol Lung Cell Mol Physiol | 2008 | https://conductscience.org/library/papers/18621912 | PubMed |
| 12 | 23383221 | Differential response of primary alveolar type I and type II cells to LPS stimulation. | PLoS One | 2013 | https://conductscience.org/library/papers/23383221 | PubMed |
| 13 | 34217425 | Acute respiratory distress syndrome. | Lancet | 2021 | https://conductscience.org/library/papers/34217425 | PubMed |
| 14 | 19494324 | Myeloperoxidase deficiency attenuates lipopolysaccharide-induced acute lung inflammation and subsequent cytokine and chemokine production. | J Immunol | 2009 | https://conductscience.org/library/papers/19494324 | PubMed |
| 15 | 34009429 | Noninvasive Measurement of Pulmonary Function in Experimental Mouse Models of Airway Disease. | Lung | 2021 | https://conductscience.org/library/papers/34009429 | PubMed |
| 16 | 34806444 | Chrysosplenol D protects mice against LPS-induced acute lung injury by inhibiting oxidative stress, inflammation, and apoptosis via TLR4-MAPKs/NF-κB signaling pathways. | Innate Immun | 2021 | https://conductscience.org/library/papers/34806444 | PubMed |
| 17 | 7075161 | Structural alterations of lung parenchyma in the adult respiratory distress syndrome. | Clin Chest Med | 1982 | https://conductscience.org/library/papers/7075161 | PubMed |
| 18 | 17884993 | Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice. | J Leukoc Biol | 2008 | https://conductscience.org/library/papers/17884993 | PubMed |
| 19 | 22850883 | The acute respiratory distress syndrome. | J Clin Invest | 2012 | https://conductscience.org/library/papers/22850883 | PubMed |
| 20 | 33068560 | Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon. | J Allergy Clin Immunol | 2021 | https://conductscience.org/library/papers/33068560 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41693482 | Digoxin attenuates LPS-induced acute lung injury in mice via NF-κB and HIF-1α inhibition. | Biomol Biomed | 2026 | https://conductscience.org/library/papers/41693482 | PubMed |
| 41105768 | A choline-sensing regulator coordinates metabolic adaptation and pathogenesis in Pseudomonas aeruginosa pulmonary infections. | Sci Adv | 2025 | https://conductscience.org/library/papers/41105768 | PubMed |
| 40943223 | Protective Antioxidant Potential of Argan Oil Versus Other Edible Oils in LPS-Challenged Mouse Heart and Kidney. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40943223 | PubMed |
| 40314003 | Curcumin-loaded nanoemulsion for acute lung injury treatment via nebulization: Formulation, optimization and in vivo studies. | ADMET DMPK | 2025 | https://conductscience.org/library/papers/40314003 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| MPO | 4353 | PubTator's text mining | https://conductscience.org/library/genes/4353 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39237657
GET https://conductscience.org/api/papers/v1/39237657/references?page=2